MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 338 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,761,000 | +36.9% | 82,956 | +1.3% | 0.04% | +31.2% |
| Q2 2016 | $4,939,000 | +30.9% | 81,908 | -0.2% | 0.03% | +28.0% |
| Q1 2016 | $3,772,000 | +74.8% | 82,044 | +83.8% | 0.02% | +92.3% |
| Q4 2015 | $2,158,000 | -1.1% | 44,635 | -13.0% | 0.01% | -7.1% |
| Q3 2015 | $2,181,000 | -38.8% | 51,315 | +64.6% | 0.01% | -33.3% |
| Q2 2015 | $3,561,000 | +1.3% | 31,181 | +14.5% | 0.02% | +5.0% |
| Q1 2015 | $3,514,000 | -32.5% | 27,226 | -47.9% | 0.02% | -33.3% |
| Q4 2014 | $5,209,000 | +13.5% | 52,298 | +12.6% | 0.03% | +11.1% |
| Q3 2014 | $4,591,000 | +48.9% | 46,437 | +16.1% | 0.03% | +58.8% |
| Q2 2014 | $3,084,000 | +80.4% | 40,007 | +50.6% | 0.02% | +70.0% |
| Q1 2014 | $1,710,000 | -12.9% | 26,570 | -13.6% | 0.01% | -9.1% |
| Q4 2013 | $1,964,000 | +13.1% | 30,769 | +6.2% | 0.01% | +22.2% |
| Q3 2013 | $1,737,000 | +108.5% | 28,979 | +71.2% | 0.01% | +80.0% |
| Q2 2013 | $833,000 | – | 16,924 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |